Vikram Thermo (India) Ltd
Incorporated in 1985, Vikram Thermo
Ltd manufactures and sells basic pharma
co-polymers[1]
- Market Cap ₹ 579 Cr.
- Current Price ₹ 185
- High / Low ₹ 216 / 90.8
- Stock P/E 22.3
- Book Value ₹ 36.2
- Dividend Yield 0.27 %
- ROCE 31.3 %
- ROE 25.6 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
Cons
- The company has delivered a poor sales growth of 11.7% over past five years.
- Debtor days have increased from 115 to 142 days.
- Working capital days have increased from 127 days to 191 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
37 | 42 | 37 | 38 | 45 | 49 | 58 | 56 | 74 | 93 | 112 | 101 | 124 | |
28 | 33 | 32 | 31 | 37 | 44 | 49 | 44 | 55 | 78 | 85 | 64 | 83 | |
Operating Profit | 9 | 9 | 5 | 8 | 8 | 5 | 9 | 12 | 18 | 15 | 26 | 37 | 41 |
OPM % | 25% | 22% | 15% | 20% | 19% | 10% | 15% | 21% | 25% | 16% | 23% | 37% | 33% |
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | -23 | |
Interest | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Depreciation | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 3 | 3 | 2 | 3 |
Profit before tax | 8 | 8 | 5 | 6 | 7 | 3 | 6 | 9 | 16 | 12 | 23 | 34 | 13 |
Tax % | 33% | 33% | 34% | 34% | 35% | 25% | 28% | 23% | 25% | 26% | 27% | 25% | |
6 | 6 | 3 | 4 | 5 | 2 | 4 | 7 | 12 | 9 | 17 | 25 | 4 | |
EPS in Rs | 2.01 | 2.04 | 1.11 | 1.51 | 1.68 | 0.84 | 1.58 | 2.30 | 3.83 | 2.76 | 5.39 | 8.08 | 1.21 |
Dividend Payout % | 15% | 15% | 13% | 20% | 20% | 12% | 19% | 13% | 8% | 2% | 0% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | 9% |
5 Years: | 12% |
3 Years: | 11% |
TTM: | 15% |
Compounded Profit Growth | |
---|---|
10 Years: | 16% |
5 Years: | 43% |
3 Years: | 30% |
TTM: | 42% |
Stock Price CAGR | |
---|---|
10 Years: | 32% |
5 Years: | 65% |
3 Years: | 66% |
1 Year: | 70% |
Return on Equity | |
---|---|
10 Years: | 17% |
5 Years: | 20% |
3 Years: | 20% |
Last Year: | 26% |
Balance Sheet
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 31 | 31 |
Reserves | 16 | 21 | 23 | 27 | 32 | 33 | 37 | 48 | 59 | 67 | 58 | 82 |
2 | 2 | 4 | 1 | 6 | 12 | 14 | 6 | 10 | 15 | 19 | 7 | |
7 | 8 | 8 | 8 | 10 | 9 | 9 | 13 | 16 | 16 | 19 | 22 | |
Total Liabilities | 30 | 36 | 41 | 41 | 53 | 60 | 66 | 73 | 92 | 104 | 127 | 143 |
9 | 9 | 10 | 17 | 21 | 30 | 34 | 34 | 32 | 53 | 61 | 61 | |
CWIP | 4 | 7 | 9 | 1 | 7 | 4 | 0 | 6 | 18 | 0 | 0 | 1 |
Investments | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 10 | 11 | 11 | 15 |
17 | 20 | 22 | 22 | 25 | 26 | 32 | 32 | 32 | 40 | 55 | 65 | |
Total Assets | 30 | 36 | 41 | 41 | 53 | 60 | 66 | 73 | 92 | 104 | 127 | 143 |
Cash Flows
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
5 | 5 | 2 | 2 | 6 | 3 | 4 | 13 | 15 | 6 | 13 | 23 | |
-4 | -4 | -3 | -1 | -10 | -8 | -2 | -10 | -19 | -7 | -13 | -9 | |
-0 | -1 | 1 | -4 | 4 | 4 | 1 | -4 | 3 | 3 | 1 | -14 | |
Net Cash Flow | 1 | 0 | -0 | -2 | -0 | -0 | 3 | -1 | -1 | 1 | 2 | -0 |
Ratios
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 87 | 95 | 131 | 139 | 115 | 139 | 138 | 129 | 99 | 93 | 109 | 142 |
Inventory Days | 68 | 62 | 64 | 64 | 98 | 60 | 53 | 97 | 94 | 74 | 64 | 137 |
Days Payable | 97 | 84 | 84 | 81 | 102 | 70 | 52 | 107 | 92 | 62 | 69 | 119 |
Cash Conversion Cycle | 59 | 72 | 111 | 123 | 111 | 128 | 139 | 119 | 101 | 106 | 104 | 160 |
Working Capital Days | 74 | 82 | 120 | 147 | 124 | 120 | 121 | 102 | 81 | 92 | 98 | 191 |
ROCE % | 40% | 33% | 16% | 20% | 19% | 8% | 14% | 17% | 24% | 15% | 25% | 31% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
16 Aug - Copy of Advertisement given in newspaper of unaudited financial results for the quarter ended on 30th June 2024 in compliance of Regulation 47 of SEBI …
- REVISED OUTCOME OF MEETING OF Board HELD ON 14TH AUGUST, 2024 14 Aug
-
Announcement under Regulation 30 (LODR)-Change in Management
14 Aug - Appointment of Mr. Dineshkumar Mistry as ID. Appointment of Mrs. Annal Safi as ID. Resignation of Mrs. Alpaben Patel as Non Executive Director. Resignation of …
- COMPLIANCE OF REGULATION 33 OF SEBI (LISTING OBLIGATIONS AND DISCLOSURES REQUIREMENTS) REGULATIONS, 2015 FOR M/S. VIKRAM THERMO (INDIA) LIMITED 14 Aug
- Board Meeting Outcome for COMPLIANCE OF REGULATION 30 OF SEBI (LISTING OBLIGATIONS AND DISCLOSURES REQUIREMENTS) REGULATIONS, 2015 FOR M/S. VIKRAM THERMO (INDIA) LIMITED. 14 Aug
Annual reports
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
-
Financial Year 2009
from bse
Business Overview:[1]
VTL is an ISO 9001, DRCOAT and
EXCiPACT International GMP certified integrated, research-based pharmaceutical excipient company. It manufactures, markets, and exports pharmaceutical excipients and chemicals.